COMBINATION THERAPY FOR REDUCTION OF TOXYCITY OF CHEMOTHERAPEUTIC AGENTS

Details for Australian Patent Application No. 2002238799 (hide)

Owner PRENDERGAST, Patrick, T.

Inventors PRENDERGAST, Patrick, T.

Pub. Number AU-A-2002238799

PCT Pub. Number WO2002/069949

Priority S2001/0209 06.03.01 IE

Filing date 5 March 2002

Wipo publication date 19 September 2002

International Classifications

A61K 031/00

A61K 031/555 - containing heavy metals, e.g. hemin, hematin, melarsoprol

A61K 031/407 - condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine

A61K 031/4375

A61K 031/352 - condensed with carbocyclic rings, e.g. cannabinols, methantheline

A61K 031/12 - Ketones

A61K 031/235

A61K 009/127 Medicinal preparations characterised by special physical form - Liposomes

A61K 009/32 Medicinal preparations characterised by special physical form

A61K 009/16 Medicinal preparations characterised by special physical form - Agglomerates

A61K 009/36 Medicinal preparations characterised by special physical form

A61P 035/00 Antineoplastic agents

A61P 031/00 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 031/04 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 031/12 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 031/18 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 033/00 Antiparasitic agents

A61P 037/06 Drugs for immunological or allergic disorders

A61K 039/395 Medicinal preparations containing antigens or antibodies - Antibodies

A61K 039/42 Medicinal preparations containing antigens or antibodies - viral

A61K 039/44 Medicinal preparations containing antigens or antibodies - Antibodies bound to carriers

A61K 031/7068

A61K 031/7072

A61K 031/52

A61K 031/522

A61K 031/7064

A61K 031/7056

A61K 031/513 - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

A61K 031/7076

A61K 031/4706 - 4-Aminoquinolines

A61K 031/4709 - Non-condensed quinolines containing further heterocyclic rings

A61K 031/505 - Pyrimidines

A61K 031/137 - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61K 031/365 - Lactones

A61K 031/155 - Amidines (), e.g. guanidine (HNC(NH)NH), isourea (HNC(OH)NH), isothiourea (HNC(SH)NH)

A61K 031/341 - not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine

A61K 031/4164 - 1,3-Diazoles

A61K 031/65 - Tetracyclines

A61K 031/473 - ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines

A61K 031/19

Event Publications

13 March 2003 Application Open to Public Inspection

  Published as AU-A-2002238799

12 February 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002238800-DIAGNOSTIC METHOD FOR GLAUCOMA

2002238798-THIN FILM MAGNETIC TAPE HEAD AND METHOD OF MANUFACTURING THEREFOR